TRAPPC2P10

Q-omics provides the consensus-scored TRAPPC2P10 profile across patient tissues and cancer cell-line models. TRAPPC2P10 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in PRAD. Additionally, TRAPPC2P10 RNA expression shows 1,015 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight PRAD, and STAD as cancer lineages where TRAPPC2P10 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes TRAPPC2P10 survival associations across molecular data types. TRAPPC2P10 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

TRAPPC2P10 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	PRAD (18)	view →

This table ranks reproducible TRAPPC2P10 RNA expression–survival associations across cancer types. High TRAPPC2P10 expression shows unfavorable associations in PRAD. The PRAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify PRAD as the clearest survival context for TRAPPC2P10 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PRAD	DFS	Tertile	All	0.089	0.935	<.001	18	view →

Pink = unfavorable, green = favorable. all 1 lineages →

TRAPPC2P10-PRAD (DFS)

Explore this curve interactively →